Adaptimmune Limited – Trademark Portfolio

Entity Type: 99

Adaptimmune Limited holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 13 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 6 are pending. Notable registered marks include TECELRA, SELTOLZA, ADAPTIMMUNE, and ADAPTIMMUNEASSIST. The owner is based in Oxfordshire.

60 Jubilee Avenue,

Milton Park Abingdon

Oxfordshire OX14 4RX , GB

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Adaptimmune Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (13 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (13 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Adaptimmune Limited have?

Adaptimmune Limited has 13 U.S. trademarks filed with the USPTO. Of these, 5 registered, 6 pending, 1 abandoned.

What trademark classes does Adaptimmune Limited file in?

Adaptimmune Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Adaptimmune Limited's most well-known trademarks?

Adaptimmune Limited's registered trademark portfolio includes well-known marks such as TECELRA, SELTOLZA, ADAPTIMMUNE, and ADAPTIMMUNEASSIST. These are among 5 currently registered trademarks in the portfolio.

What is Adaptimmune Limited's trademark registration success rate?

Adaptimmune Limited has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 6 applications are pending review.